UPDATE : Tuesday, August 14, 2018
상단여백
Huons Global posts ₩93.2 billion in Q2 sales by Lee Han-soo 2018-08-14 15:22
Psoriasis drug Tremfya may add indication for Crohn’s disease by Lee Hye-seon 2018-08-14 12:07
US court to proceed with Pfizer’s lawsuit against J&J by Lee Han-soo 2018-08-14 10:51
Parkinson’s drug Azilect beats market leader Stalevo by So Jae-hyeon 2018-08-13 15:32
13 gadolinium contrast agents banned until year-end by Lee Hye-seon 2018-08-13 14:36
라인
Huons to conduct clinical trials for BTX for eye wrinkles by Lee Han-soo 2018-08-13 14:21
[News Focus] Valsartan chaos reveals Korean drugmakers’ weakness by So Jae-hyeon 2018-08-13 14:21
Janssen Korea to observe 120 for post-marketing survey of ulcerative colitis treatment by Lee Hye-seon 2018-08-10 18:25
Pfizer Vitals suffers double-whammy from poor performance, valsartan recall by So Jae-hyun 2018-08-10 17:56
Cannabinoid group uses blockchain to conduct clinical trials on CBD by Lee Han-soo 2018-08-10 14:53
라인
Daewoong, Chong Kun Dang compete to develop dementia treatments by So Jae-hyun 2018-08-09 15:55
JW to launch drug combining Livaro, Ezetimibe by Lee Hye-seon 2018-08-09 11:59
Competition heats up among Korean Botox makers to develop ‘kDa’ by So Jae-hyeon 2018-08-08 16:53
GSK publishes SWORD data on 2-drug HIV regimen by Marian Chu 2018-08-08 14:42
Takeda gets approval for antihypertension drug Edarbyclor by Marian Chu 2018-08-07 17:24
라인
Bukwang registers patients for P2 clinical trial of diabetes treatment by Lee Han-soo 2018-08-07 17:24
Over 36.8 billion won worth of banned valsartan-based drugs sold last year by So Jae-hyeon 2018-08-07 15:40
59 Korea-made high blood pressure medications called back over cancer fears by Marian Chu 2018-08-06 17:50
Chong Kun Dang gets license for generic immunosuppressant by So Jae-hyeon 2018-08-03 15:38
GC Labcell, AbClon to develop CAR-NK cell treatment by Lee Han-soo 2018-08-03 14:40
여백
여백
여백
Back to Top